SAN JOSE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it plans to report its financial results for the third quarter ended September 30, 2005 after the close of market on November 10.
VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PST / 5:00 p.m. EST on November 10. This call will be webcast live for all investors and archived on the company’s website at www.vnus.com.
How to Access the Teleconference Webcast VNUS Medical Technologies Third-Quarter 2005 Teleconference November 10, 2005 2:00 p.m. PST / 5:00 p.m. EST
Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly. In addition to the webcast replay, a phone replay will be available for seven days after the live call at 719-457-0820, code number 8845594.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. For more information, please visit the company’s website at www.vnus.com.
VNUS Medical Technologies, Inc.
CONTACT: Tim Marcotte, Vice President, Finance and Administration, ChiefFinancial Officer of VNUS Medical Technologies, Inc., +1-408-473-1199, orir@vnus.com